Ipsen Overview
Contact top employees from
Ipsen
Summary
Ipsen is a public company that has been in the industry for 96 years. The company currently specializes in the Pharmaceuticals, Pharmaceuticals areas. The position of the CEO is occupied by David Loew. Its headquarters is located at Boulogne-Billancourt, Other, FR. The number of employees ranges from 5.0K to 10K. The annual revenue of Ipsen varies between 1.0B and 5.0B. To connect with Ipsen employee register on SignalHire.
Ipsen industries
Pharmaceuticals
Headquarters Location
Ipsen Employees Size
5000-10000 employees
Specialties
Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, Primary Care
SIC Code
2834
Founded
1929
Estimated Annual Revenue
$1.0B - 5.0B
Operating Status
Independent Company
Ipsen Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 1901 | Public Company | 10K - 50K | 16.4B | $11.4B | |
| 1988 | Public Company | 5.0K - 10K | 12.4B | $2.1B | |
| 1948 | Public Company | 1.0K - 5.0K | 682.4M | $320.5M | |
| 1888 | Public Company | 100K - 9.9M | 40.2B | $6.9M | |
| 2015 | Privately Held | 100 - 250 | < 1M | $0 | |
| 1996 | Public Company | 100K - 9.9M | 50.4B | $0 | |
| 1848 | Public Company | 50K - 100K | 55.5B | $0 | |
| 1935 | Public Company | 10K - 50K | 2.6B | $0 | |
| 1994 | Public Company | 50K - 100K | 45.6B | $0 | |
| 1891 | Public Company | 50K - 100K | 50.1B | $0 | |
| 1830 | Public Company | 50K - 100K | 45.5B | $0 | |
| 1876 | Public Company | 10K - 50K | 26.7B | $0 | |
| 1886 | Public Company | 100K - 9.9M | 89.2B | $0 | |
| 1954 | - | - | $- | ||
| 1896 | - | 10000+ | - | $- | |
| 1980 | - | 10000+ | - | $- |
Traffic on Ipsen Company’s website
Ipsen Employees Turnover 2 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Current employees switched from
6
Ipsen
3
Novartis
2
Sanofi
2
Ironwood Pharmaceuticals
3
AstraZeneca
3
Bristol Myers Squibb
Ex-employees switched to
B7
Ipsen
B2
Bristol Myers Squibb
B
2
UCB
B
2
Roche
B
2
KalVista Pharmaceuticals, Inc.
B3
AstraZeneca
Number of employees by department
Total number all of employee turnover
Ex-employees positions
In Company
In New Company
Contact top employees from
Ipsen
Shih Lung Woo
Medical Science Liaison
Jonathan Bouchard
Heath Economics and Outcomes Research - Neuroscience
Roberta Toporovski
Sr. Director; Asset Operations Lead
Jessica Hurtig
Medical Science Liaison
Aaron Angeli
Regional Business Director
Evan Roche
QA Specialist II
Mercedes Farhat
Senior Medical Science Liaison - Neuroscience
Raymond Walsh
Clinical Contracts Manager
Ron Springston
Sr. Director Corporate Accounts-West
Yuval Gilis
Senior Director, M&A & Corporate Finance
Bryan DePriest
Senior Clinical Science Specialist - Rare Disease
Marc Mazzuca
Director, Global Regulatory Affairs
Sharon Chase
Senior Director, Head of Finance - Rare Disease
Elliott Brand
Senior Clinical Sales Specialist
Philippe Lopes
Executive Vice President, Chief Business Officer
Emily Kelley
Business Operations Specialist
Jennifer Milan
Clinical Science Specialist
Mike Koerner
Senior Clinical Science Specialist-Liver
Monica Raziq
Associate Director, Medical Affairs
Tony DiPierno
Director, Patient Services
João Carlos de Britto
Region Head Latin America & General Manager Brazil
Vitaly Doban
VP, Head of Data, Insights & AI
James Otto
Senior Global Medical Affairs Director, External Innovation and New Products Strategy
Suren Raveendran
Vice President Finance, R&D and Global Medical
Alex Gonzales
Senior Director, HR Business Partner & Integrations
Shrutej Patel
Director, Government Pricing, Commercial / Gov’t Contracts & Medicaid
Payal Shah
Associate Director, Global Regulatory Affairs, Oncology
Eduardo Molina
Vice President, Business Operations, Strategy and Chief of Staff to North America President
John Martinez MEd
Sr. Patient Education Liaison
Alan Blevins
Head of Talent Acquisition, North America
